Literature DB >> 3156200

Electrocardiographic and vectorcardiographic study of interatrial conduction disturbances with left atrial retrograde activation.

A Bayes de Luna, R Fort de Ribot, E Trilla, J Julia, J Garcia, J Sadurni, J Riba, F Sagues.   

Abstract

From 81,000 ECGs we collected 83 cases that fulfilled the criteria of Interatrial Conduction Disturbances with Left Atrial Retrograde Activation (IACD-LARA) (P +/- in II, III and VF with P width greater than or equal to 120 msec.). We present the detailed study of 35 cases with surface ECG and VCG and 29 cases with orthogonal ECG leads. The results are then compared against two control groups: with cardiopathy (30 cases) and without cardiopathy (25 cases). The prevalence of IACD-LARA was nearly 1% globally, and 2% among patients with valvular heart disease. The diagnostic criteria for IACD-LARA are: 1) ECG: P +/- in II, III and VF with P greater than or equal to 120 msec. with open angle (usually greater than 90 degrees) between the first and the second part of the P.2) Orthogonal ECG: P +/- in Y lead with a negative mode greater than 40 msec. 3) VCG: More than 50 msec. above the X or Z axis, duration of the P loop greater than or equal to 110 msec., open angle between the two parts of the P loop in both frontal (131.3 degrees +/- 32.3) and right sagital planes (171.2 degrees +/- 15.1), and presence of notches and slurrings in the last part of the P loop.

Entities:  

Mesh:

Year:  1985        PMID: 3156200     DOI: 10.1016/s0022-0736(85)80029-7

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  29 in total

Review 1.  Atrial pacing to prevent atrial fibrillation?

Authors:  S M Sopher; A J Camm
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

2.  The P-wave morphology: what does it tell us?

Authors:  Adrian Baranchuk; Antoni Bayés de Luna
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-09

Review 3.  Bayes Syndrome and Imaging Techniques.

Authors:  Ivan Hernandez-Betancor; Maria Manuela Izquierdo-Gomez; Javier Garcia-Niebla; Ignacio Laynez-Cerdena; Martin Jesus Garcia-Gonzalez; A Barragan-Acea; Jose Luis Irribarren-Sarria; Juan Jose Jimenez-Rivera; Juan Lacalzada-Almeida
Journal:  Curr Cardiol Rev       Date:  2017

Review 4.  Intra- and interatrial conduction abnormalities: hemodynamic and arrhythmic significance.

Authors:  Nicolas Johner; Mehdi Namdar; Dipen C Shah
Journal:  J Interv Card Electrophysiol       Date:  2018-08-20       Impact factor: 1.900

Review 5.  P-wave morphology: underlying mechanisms and clinical implications.

Authors:  Pyotr G Platonov
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-07       Impact factor: 1.468

6.  Anticoagulation in patients at high risk of stroke without documented atrial fibrillation. Time for a paradigm shift?

Authors:  Antoni Bayés de Luna; Adrian Baranchuk; Manuel Martínez-Sellés; Pyotr G Platonov
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-12-16       Impact factor: 1.468

Review 7.  The Diagnosis and Clinical Implications of Interatrial Block.

Authors:  Antonio Bayés de Luna; Albert Massó-van Roessel; Luis Alberto Escobar Robledo
Journal:  Eur Cardiol       Date:  2015-07

8.  Rationale and design of the BAYES (Interatrial Block and Yearly Events) registry.

Authors:  Manuel Martínez-Sellés; Adrian Baranchuk; Roberto Elosua; Antonio Bayés de Luna
Journal:  Clin Cardiol       Date:  2016-11-24       Impact factor: 2.882

9.  Altered interatrial conduction detected in MADIT II patients bound to develop atrial fibrillation.

Authors:  Fredrik Holmqvist; Pyotr G Platonov; Jonas Carlson; Wojciech Zareba; Arthur J Moss
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-07       Impact factor: 1.468

10.  Evolution of P-wave morphology in healthy individuals: a 3-year follow-up study.

Authors:  Rasmus Havmöller; Jonas Carlson; Fredrik Holmqvist; Bertil Olsson; Pyotr Platonov
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-07       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.